Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

NCT05517421 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease

Interventions

DRUG: Batoclimab
DRUG: Placebo

Sponsor

Immunovant Sciences GmbH